CX3CL1 and neuropathic pain: Another example involves nociceptors expressing chemokines, such as fractalkine (CX3CL1), which can lead to microglial activation via the activation of its receptor CX3CR1, resulting in intracellular phosphorylation of p38 mitogen-activated protein kinase (MAPK) during neuropathic pain [56].